EMG
TLIS

ETF Managers Group’s Talis Biomedical Corporation Common Stock TLIS Stock Holding History

ETF Managers Group’s Portfolio TLIS Stock Details TLIS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-530
Closed -$32K – 756
2021
Q4 		$32K Sell
530
-90
-15% -$6.73K ﹤0.01% 676
2021
Q3 		$56K Buy
620
+116
+23% +$15.5K ﹤0.01% 653
2021
Q2 		$81K Sell
504
-21
-4% -$3.57K ﹤0.01% 628
2021
Q1 		$90K Buy
+525
New +$131K ﹤0.01% 642

Other funds holding TLIS

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
GC
Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PCM
Prelude Capital Management New York $1.37B AUM 71.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

ETF Managers Group's TLIS Position: Q1 2022 in Review

ETF Managers Group sold out of Talis Biomedical Corporation Common Stock (TLIS) in Q1 2022, closing a stake of 530 shares — an estimated $32K sold.

ETF Managers Group first reported a position in TLIS in Q1 2021 and held it in 4 quarters. The position peaked at $90K in Q1 2021. 44 funds tracked by Wall St. Rank hold TLIS as of Q1 2022.

  • ETF Managers Group reported no remaining Talis Biomedical Corporation Common Stock position as of Q1 2022 after selling out during the quarter.
  • ETF Managers Group sold 530 Talis Biomedical Corporation Common Stock shares in Q1 2022, an estimated $32K.
  • ETF Managers Group first reported a position in Talis Biomedical Corporation Common Stock in Q1 2021 and held it in 4 quarters.
  • ETF Managers Group's Talis Biomedical Corporation Common Stock position peaked at $90K in Q1 2021.
  • 44 funds tracked by Wall St. Rank held Talis Biomedical Corporation Common Stock as of Q1 2022.

Based on ETF Managers Group's 13F filing for Q1 2022, filed 13 May 2022.